These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38007947)
1. A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache. Brandt RB; Wilbrink LA; de Coo IF; Haan J; Mulleners WM; Huygen FJPM; van Zwet EW; Ferrari MD; Fronczek R; EBioMedicine; 2023 Dec; 98():104895. PubMed ID: 38007947 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial. Wilbrink LA; de Coo IF; Doesborg PGG; Mulleners WM; Teernstra OPM; Bartels EC; Burger K; Wille F; van Dongen RTM; Kurt E; Spincemaille GH; Haan J; van Zwet EW; Huygen FJPM; Ferrari MD; Lancet Neurol; 2021 Jul; 20(7):515-525. PubMed ID: 34146510 [TBL] [Abstract][Full Text] [Related]
3. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Wilbrink LA; Teernstra OP; Haan J; van Zwet EW; Evers SM; Spincemaille GH; Veltink PH; Mulleners W; Brand R; Huygen FJ; Jensen RH; Paemeleire K; Goadsby PJ; Visser-Vandewalle V; Ferrari MD Cephalalgia; 2013 Nov; 33(15):1238-47. PubMed ID: 23720502 [TBL] [Abstract][Full Text] [Related]